"Designing Growth Strategies is in our DNA"

Oncology Drugs Market Size, Share & COVID-19 Impact Analysis, By Drugs Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, and Others), By Therapy (Chemotherapy, Targeted Therapy, and Immunotherapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer), By Dosage Form (Solid, Liquid), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies) and Regional Forecast, 2020-2027

Region : Global | Format: PDF | Report ID: FBI103431

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Key Indications (Lung Cancer, Breast Cancer, Prostate Cancer, etc.), By Region/Country
    2. Overview of Different Oncology Drugs with respect to Regulatory Approvals and Clinical Trials
    3. Pricing Analysis, By Key Players
    4. Recent Advancements in Development of Oncology Drugs
    5. Key Industry Developments (Mergers, Acquisitions, and Partnerships)
    6. Impact of COVID-19 on Oncology Drugs Market
  5. Global Oncology Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    3. Market Analysis, Insights and Forecast – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    4. Market Analysis, Insights and Forecast – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    5. Market Analysis, Insights and Forecast – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    6. Market Analysis, Insights and Forecast- By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    7. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Oncology Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    3. Market Analysis – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    4. Market Analysis – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    5. Market Analysis – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    6. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Oncology Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    3. Market Analysis – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    4. Market Analysis – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    5. Market Analysis – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    6. Market Analysis, Insights and Forecast- By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    7. Market Analysis – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Oncology Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    3. Market Analysis – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    4. Market Analysis – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    5. Market Analysis – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    6. Market Analysis, Insights and Forecast- By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    7. Market Analysis – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Oncology Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    3. Market Analysis – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    4. Market Analysis – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    5. Market Analysis – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    6. Market Analysis, Insights and Forecast- By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    7. Market Analysis – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Oncology Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    3. Market Analysis – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    4. Market Analysis – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    5. Market Analysis – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    6. Market Analysis, Insights and Forecast- By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    7. Market Analysis – By Country/Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, Strategies, Financials (based on availability))
      1. AbbVie Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. Strategies,
        6. Financials (based on availability)
      2. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. Strategies,
        6. Financials (based on availability)
      3. Novartis AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. Strategies,
        6. Financials (based on availability)
      4. Millennium Pharmaceuticals, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. Strategies,
        6. Financials (based on availability)
      5. Pfizer Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. Strategies,
        6. Financials (based on availability)
      6. AstraZeneca
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. Strategies,
        6. Financials (based on availability)
      7. CELGENE CORPORATION
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. Strategies,
        6. Financials (based on availability)
      8. Bristol-Myers Squibb Company
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. Strategies,
        6. Financials (based on availability)
      9. Others
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. Strategies,
        6. Financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 01: Global Oncology Drugs Market Value Share (%), by Drug Class, 2019 & 2027

Figure 2: Global Oncology Drugs Market Forecast (US$ Bn), by Cytotoxic Drugs, 2016-2027

Figure 3: Global Oncology Drugs Market Forecast (US$ Bn), by Targeted Drugs, 2016-2027

Figure 4: Global Oncology Drugs Market Forecast (US$ Bn), by Hormonal Drugs, 2016-2027

Figure 5: Global Oncology Drugs Market Forecast (US$ Bn), by Others, 2016-2027

Figure 06: Global Oncology Drugs Market Value Share (%), by Therapy, 2019 & 2027

Figure 7: Global Oncology Drugs Market Forecast (US$ Bn), by Chemotherapy, 2016-2027

Figure 8 Global Oncology Drugs Market Forecast (US$ Bn), by Targeted Therapy, 2016-2027

Figure 9: Global Oncology Drugs Market Forecast (US$ Bn), by Immunotherapy, 2016-2027

Figure 10: Global Oncology Drugs Market Value Share (%), by Indication, 2019 & 2027

Figure 11: Global Oncology Drugs Market Forecast (US$ Bn), by Lung Cancer, 2016-2027

Figure 12 Global Oncology Drugs Market Forecast (US$ Bn), by Stomach Cancer, 2016-2027

Figure 13: Global Oncology Drugs Market Forecast (US$ Bn), by Colorectal Cancer, 2016-2027

Figure 14: Global Oncology Drugs Market Forecast (US$ Bn), by Breast Cancer, 2016-2027

Figure 15: Global Oncology Drugs Market Forecast (US$ Bn), by Prostate Cancer, 2016-2027

Figure 16: Global Oncology Drugs Market Forecast (US$ Bn), by Others, 2016-2027

Figure 17: Global Oncology Drugs Market Value Share (%), by Dosage Form, 2019 & 2027

Figure 18: Global Oncology Drugs Market Forecast (US$ Bn), by Solid, 2016-2027

Figure 19: Global Oncology Drugs Market Forecast (US$ Bn), by Liquid, 2016-2027

Figure 20: Global Oncology Drugs Market Forecast (US$ Bn), by Injectable, 2016-2027

Figure 21: Global Oncology Drugs Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 22: Global Oncology Drugs Market Forecast (US$ Bn), by Hospital Pharmacies, 2016-2027

Figure 23: Global Oncology Drugs Market Forecast (US$ Bn), by Retail Pharmacies, 2016-2027

Figure 24: Global Oncology Drugs Market Forecast (US$ Bn), by Online Pharmacies, 2016-2027

Figure 25: Global Oncology Drugs Market Forecast (US$ Bn), by Others, 2016-2027

Figure 26: Global Oncology Drugs Market Value Share (%), by Region, 2019 & 2027

Figure 27: North America Oncology Drugs Market Value (US$ Bn), by Country, 2019 & 2027

Figure 28: North America Oncology Drugs Market Value Share (%), by Country, 2019

Figure 29: North America Oncology Drugs Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 30: North America Oncology Drugs Market Value Share (%), by Drug Class, 2019

Figure 31: North America Oncology Drugs Market Value (US$ Bn), by Therapy, 2019 & 2027

Figure 32: North America Oncology Drugs Market Value Share (%), by Therapy 2019

Figure 33: North America Oncology Drugs Market Value (US$ Bn), by Indication, 2019 & 2027

Figure 34: North America Oncology Drugs Market Value Share (%), by Indication, 2019

Figure 35: North America Oncology Drugs Market Value (US$ Bn), by Dosage Form, 2019 & 2027

Figure 36: North America Oncology Drugs Market Value Share (%), by Dosage Form, 2019

Figure 37: North America Oncology Drugs Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 38: North America Oncology Drugs Market Value Share (%), by Distribution Channel, 2019

Figure 39: Europe Oncology Drugs Market Value (US$ Bn), by Country, 2019 & 2027

Figure 40: Europe Oncology Drugs Market Value Share (%), by Country, 2019

Figure 41: Europe Oncology Drugs Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 42: Europe Oncology Drugs Market Value Share (%), by Drug Class, 2019

Figure 43: Europe Oncology Drugs Market Value (US$ Bn), by Therapy, 2019 & 2027

Figure 44: Europe Oncology Drugs Market Value Share (%), by Therapy, 2019

Figure 45: Europe Oncology Drugs Market Value (US$ Bn), by Indication, 2019 & 2027

Figure 46: Europe Oncology Drugs Market Value Share (%), by Indication, 2019

Figure 47: Europe Oncology Drugs Market Value (US$ Bn), by Dosage Form, 2019 & 2027

Figure 48: Europe Oncology Drugs Market Value Share (%), by Dosage Form, 2019

Figure 49: Europe Oncology Drugs Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 50: Europe Oncology Drugs Market Value Share (%), by Distribution Channel, 2019

Figure 51: Asia Pacific Oncology Drugs Market Value (US$ Bn), by Country, 2019 & 2027

Figure 52: Asia Pacific Oncology Drugs Market Value Share (%), by Country, 2019

Figure 53: Asia Pacific Oncology Drugs Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 54: Asia Pacific Oncology Drugs Market Value Share (%), by Drug Class, 2019

Figure 55: Asia Pacific Oncology Drugs Market Value (US$ Bn), by Therapy, 2019 & 2027

Figure 56: Asia Pacific Oncology Drugs Market Value Share (%), by Therapy, 2019

Figure 57: Asia Pacific Oncology Drugs Market Value (US$ Bn), by Indication, 2019 & 2027

Figure 58: Asia Pacific Oncology Drugs Market Value Share (%), by Indication, 2019

Figure 59: Asia Pacific Oncology Drugs Market Value (US$ Bn), by Dosage Form, 2019 & 2027

Figure 60: Asia Pacific Oncology Drugs Market Value Share (%), by Dosage Form, 2019

Figure 61: Asia Pacific Oncology Drugs Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 62: Asia Pacific Oncology Drugs Market Value Share (%), by Distribution Channel, 2019

Figure 63: Latin America Oncology Drugs Market Value (US$ Bn), by Country, 2019 & 2027

Figure 64: Latin America Oncology Drugs Market Value Share (%), by Country, 2019

Figure 65: Latin America Oncology Drugs Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 66: Latin America Oncology Drugs Market Value Share (%), by Drug Class, 2019

Figure 67: Latin America Oncology Drugs Market Value (US$ Bn), by Therapy, 2019 & 2027

Figure 68: Latin America Oncology Drugs Market Value Share (%), by Therapy, 2019

Figure 69: Latin America Oncology Drugs Market Value (US$ Bn), by Indication, 2019 & 2027

Figure 70: Latin America Oncology Drugs Market Value Share (%), by Indication, 2019

Figure 71: Latin America Oncology Drugs Market Value (US$ Bn), by Dosage Form, 2019 & 2027

Figure 72: Latin America Oncology Drugs Market Value Share (%), by Dosage Form, 2019

Figure 73: Latin America Oncology Drugs Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 74: Latin America Oncology Drugs Market Value Share (%), by Distribution Channel, 2019

Figure 75: Middle East & Africa Oncology Drugs Market Value (US$ Bn), by Country, 2019 & 2027

Figure 76: Middle East & Africa Oncology Drugs Market Value Share (%), by Country, 2019

Figure 77: Middle East & Africa Oncology Drugs Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 78: Middle East & Africa Oncology Drugs Market Value Share (%), by Drug Class, 2019

Figure 79: Middle East & Africa Oncology Drugs Market Value (US$ Bn), by Therapy, 2019 & 2027

Figure 80: Middle East & Africa Oncology Drugs Market Value Share (%), by Therapy, 2019

Figure 81: Middle East & Africa Oncology Drugs Market Value (US$ Bn), by Indication, 2019 & 2027

Figure 82: Middle East & Africa Oncology Drugs Market Value Share (%), by Indication, 2019

Figure 83: Middle East & Africa Oncology Drugs Market Value (US$ Bn), by Dosage Form, 2019 & 2027

Figure 84: Middle East & Africa Oncology Drugs Market Value Share (%), by Dosage Form, 2019

Figure 85: Middle East & Africa Oncology Drugs Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 86: Middle East & Africa Oncology Drugs Market Value Share (%), by Distribution Channel, 2019

Table 01: Global Oncology Drugs Market Revenue (US$ Bn) Forecast, by Drug Class, 2016–2027

Table 02: Global Oncology Drugs Market Revenue (US$ Bn) Forecast, by Cytotoxic Drugs, 2016–2027

Table 03: Global Oncology Drugs Market Revenue (US$ Bn) Forecast, by Targeted Drugs, 2016–2027

Table 04: Global Oncology Drugs Market Revenue (US$ Bn) Forecast, by Therapy, 2016–2027

Table 05: Global Oncology Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2016-2027

Table 06: Global Oncology Drugs Market Revenue (US$ Bn) Forecast, by Dosage Form, 2016-2027

Table 07: Global Oncology Drugs Market Revenue (US$ Bn) Forecast, by Solid, 2016-2027

Table 08: Global Oncology Drugs Market Revenue (US$ Bn) Forecast, by Injectable, 2016-2027

Table 09: Global Oncology Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016–2027

Table 10: Global Oncology Drugs Market Revenue (US$ Bn) Forecast, by Region, 2016–2027

Table 11: North America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Country, 2016–2027

Table 12: North America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Drug Class, 2016–2027

Table 13: North America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Cytotoxic Drugs, 2016–2027

Table 14: North America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Targeted Drugs, 2016–2027

Table 15: North America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Therapy, 2016–2027

Table 16: North America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2016–2027

Table 17: North America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Dosage Form, 2016–2027

Table 18: North America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Solid, 2016–2027

Table 19: North America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Injectable, 2016–2027

Table 20: North America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016–2027

Table 21: Europe Oncology Drugs Market Revenue (US$ Bn) Forecast, by Country, 2016-2027

Table 22: Europe Oncology Drugs Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 23: Europe Oncology Drugs Market Revenue (US$ Bn) Forecast, by Cytotoxic Drugs, 2016–2027

Table 24: Europe Oncology Drugs Market Revenue (US$ Bn) Forecast, by Targeted Drugs, 2016–2027

Table 25: Europe Oncology Drugs Market Revenue (US$ Bn) Forecast, by Therapy, 2016–2027

Table 26: Europe Oncology Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2016–2027

Table 27: Europe Oncology Drugs Market Revenue (US$ Bn) Forecast, by Dosage Form, 2016–2027

Table 28: Europe Oncology Drugs Market Revenue (US$ Bn) Forecast, by Solid, 2016–2027

Table 29: Europe Oncology Drugs Market Revenue (US$ Bn) Forecast, by Injectable, 2016–2027

Table 30: Europe Oncology Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016–2027

Table 31: Asia Pacific Oncology Drugs Market Revenue (US$ Bn) Forecast, by Country, 2016-2027

Table 32: Asia Pacific Oncology Drugs Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 33: Asia Pacific Oncology Drugs Market Revenue (US$ Bn) Forecast, by Cytotoxic Drugs, 2016–2027

Table 34: Asia Pacific Oncology Drugs Market Revenue (US$ Bn) Forecast, by Targeted Drugs, 2016–2027

Table 35: Asia Pacific Oncology Drugs Market Revenue (US$ Bn) Forecast, by Therapy, 2016–2027

Table 36: Asia Pacific Oncology Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2016–2027

Table 37: Asia Pacific Oncology Drugs Market Revenue (US$ Bn) Forecast, by Dosage Form, 2016–2027

Table 38: Asia Pacific Oncology Drugs Market Revenue (US$ Bn) Forecast, by Solid, 2016–2027

Table 39: Asia Pacific Oncology Drugs Market Revenue (US$ Bn) Forecast, by Injectable, 2016–2027

Table 40: Asia Pacific Oncology Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016–2027

Table 41: Latin America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Country, 2016–2027

Table 42: Latin America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 43: Latin America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Cytotoxic Drugs, 2016–2027

Table 44: Latin America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Targeted Drugs, 2016–2027

Table 45: Latin America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Therapy, 2016–2027

Table 46: Latin America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2016–2027

Table 47: Latin America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Dosage Form, 2016–2027

Table 48: Latin America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Solid, 2016–2027

Table 49: Latin America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Injectable, 2016–2027

Table 50: Latin America Oncology Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016–2027

Table 51: Middle East & Africa Oncology Drugs Market Revenue (US$ Bn) Forecast, by Country, 2016–2027

 class=
  • Aug, 2020
  • 2019
  • 2016-2018
  • 160

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X